The following statement is being issued by Branstetter, Stranch & Jennings, PLLC regarding In re Prograf Antitrust Litigation.
A lawsuit is currently pending claiming that Astellas Pharma US, Inc. (“Astellas” or “Defendant”) violated state antitrust, unfair competition, consumer protection, and unjust enrichment laws of certain states by delaying the availability of a less expensive generic version of the immunosuppressant prescription drug Prograf® (known as tacrolimus). Plaintiffs allege that Defendant’s conduct caused some consumers and third party payors to pay too much for Prograf in certain states from September 3, 2008 to December 31, 2010 (also referred to as the “Class Damage Period”). This lawsuit does not claim that Prograf is unsafe or ineffective. Astellas denies any wrongdoing.
To view the multimedia release go to:
http://www.multivu.com/players/English/7933851-prograf-antitrust-class-action-settlement/
Tanger Factory Outlet Centers, Inc. announced today that in honor of the 25th annual Tanger PINK Campaign it will again offer shoppers great savings in return for supporting the ongoing efforts to end breast cancer during the month of October.
Launching today at Tanger Outlets across the United States and Canada, the Tanger PINK Campaign offers shoppers using the Shop Pink Card the opportunity to receive additional savings on the best brand name and designer fashions while helping to unite in the fight against breast cancer.
To view the multimedia release go to:
https://www.multivu.com/players/English/8385651-tanger-outlets-tanger-pink-campaign-against-breast-cancer/
Quadriplegic former IndyCar driver and current team owner Sam Schmidt completed the bottom half of the challenging, high-altitude Broadmoor Pikes Peak International Hill Climb yesterday in the Arrow Electronics, Inc. (NYSE:ARW) Semi-Autonomous Motorcar (SAM car).
Schmidt, who was paralyzed from the neck down in a crash during an IndyCar practice lap in 2000, is able to steer, accelerate and brake the modified 2016 Corvette Z06 SAM car using only his head. Sensors mounted on an Arrow-designed high-tech headset that Schmidt wears connect to infrared cameras mounted on the dashboard and detect his head-tilt motions to steer. A sip-and-puff device that Smith breathes into enables him to accelerate and brake.
Inspire Medical Systems, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Inspire Upper Airway Stimulation (UAS) therapy for use in a subset of patients with moderate to severe Obstructive Sleep Apnea (OSA) who are unable to use Continuous Positive Airway Pressure (CPAP). Inspire therapy is a fully implanted neurostimulation device, the first of its kind for sleep apnea, that provides an alternative treatment that is proven, convenient and easy to use.
To view the Multimedia News Release, go to: http://www.multivu.com/mnr/7169651-fda-approves-inspire-upper-airway-stimulation-therapy-sleep-apnea
Yellow Checker Cab Company, Inc. has connected passengers with trusted taxicab operators since 1938.Yellow Checker Cab’s Connect2Taxi call center will connect you to a licensed & insured taxicab in your area.
http://www.legalenglish.com/
Dena Falken is an International lawyer and Seminar presenter for Legal-Ease International Inc. a Worldwide company training Foreign Lawyers in Legal English and a wide range of services.
Visit www.legalenglish.com
EnteroMedics Inc. (NASDAQ: ETRM) today announced that the U.S. Food and Drug Administration (FDA) has approved VBLOC® vagal blocking therapy, delivered via the Maestro® System, for the treatment of adult patients with obesity who have a Body Mass Index (BMI) of at least 40 to 45 kg/m2, or a BMI of at least 35 to 39.9 kg/m2 with a related health condition such as high blood pressure or high cholesterol levels, and who have tried to lose weight in a supervised weight management program within the past five years. The Maestro System is the first new medical device to be approved by the FDA for obesity in over ten years. EnteroMedics anticipates that the device will be available, on a limited basis, at select Bariatric Centers of Excellence in the U.S. this year. The Maestro System has received CE Mark and is listed on the Australian Register of Therapeutic Goods.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7269351-enteromedics-fda-approval-vbloc-maestro-system-weight-loss-device/
Miral and SeaWorld Entertainment, Inc. (NYSE:SEAS) (“SeaWorld”) today announced their partnership to develop SeaWorld Abu Dhabi, a first-of-its-kind marine life themed park on Yas Island. This next generation SeaWorld Abu Dhabi will also include the United Arab Emirates’ (“UAE”) first dedicated marine life research, rescue, rehabilitation and return center with world-class facilities and resources for the care and conservation of local marine life. SeaWorld Abu Dhabi will be the first new SeaWorld without orcas, and will integrate up-close animal experiences, mega attractions and a world class aquarium, bringing the latest technology in visitor engagement.
The partnership brings together Miral’s expertise in developing Yas Island’s portfolio of destinations with SeaWorld’s 50-plus years of theme park, veterinary medicine, marine science and zoological practice and experience.
To view the multimedia release go to:
http://www.multivu.com/players/uk/8002251-miral-announces-seaworld-yas-island/
Nu Skin Enterprises, Inc. (NYSE: NUS) today announced the consumer launch of ageLOC LumiSpa, the first-of-its-kind, dual-action skin care device that treats and cleanses the skin. Following successful market previews, ageLOC LumiSpa is now available in the Americas and EMEA regions with launches to follow in North Asia, Greater China and Southeast Asia over the next three months.
ageLOC LumiSpa simultaneously delivers a skin-perfecting treatment and superior cleansing benefits to reveal smoother, softer skin after just one use. Now Nu Skin customers can be confident that their skin is clean, radiant and always ready for the perfect selfie or spontaneous photo moment.
To view the multimedia release go to:
https://www.multivu.com/players/English/8239151-nu-skin-care-device-ageloc-lumispa/
Jockey International, Inc. (Jockey), a 140-year-old brand recognized around the world for its premium underwear and apparel, today announced an addition to its inspiring brand campaign “Show ’Em What’s Underneath, Show ’Em Your Jockey.” The newest hero to be featured is former Navy SEAL and actor, Remi Adeleke, who shows people that with resilience, you can accomplish anything.
The #ShowEm campaign introduces Remi proudly wearing Jockey in a personal, intimate video and series of portraits illustrating what’s underneath, both literally and figuratively. #ShowEm honors everyday heroes who embody the spirit and values of Jockey and the characteristics that make them unique, including resilience, perseverance, courage, family and hope.
To view the multimedia release go to:
https://www.multivu.com/players/English/8118951-jockey-show-em-whats-underneath/
According to recent findings from Campos Inc., food customization is one of this year’s top consumer trends. Now, more than ever, consumers find endless options when it comes to customizing food – whether they are eating in or dining out. Along with exploring different flavors and food pairings, the baking industry is rethinking how they package recipes to consumers. In fact, according to Mintel, 45% of consumers surveyed want multiple preparation options and recipes listed on the packaging to allow them to express their personality.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7519851-lucky-leaf-customizable-desserts/
http://www.fixthedebt.org/ - A recent report highlights the need to strengthen Social Security's finances. A new, interactive tool allows you to make the choices to preserve it for future generations.
